North Baltimore Journal

There were four companies in cities associated with Baltimore County, Maryland, that received four FDA inspections in the fourth quarter of 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 33.3% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.

Most of the companies inspected at the time were involved in the Biologics sector. Both the Food and Cosmetics and Devices sectors sectors tied for second most common type.

There were two companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Company Name	Area of Business	Inspection Date	Result
Case-Mason Filling, Inc.	Food and Cosmetics	11/02/2023	No Action Indicated (NAI)
Greater Baltimore Medical Center	Biologics	10/26/2023	Voluntary Action Indicated (VAI)
Shady Grove Fertility Reproductive Science Center	Biologics	10/23/2023	No Action Indicated (NAI)
Shikani Medical, LLC	Devices	12/21/2023	Voluntary Action Indicated (VAI)